Consortium for the Prevention and Management of the Serious Side Effects of Cancer Chemotherapy
Preventing and managing the serious side effects of cancer chemotherapy. Consortium for the Prevention and Management of the Serious Side Effects of Cancer Chemotherapy
Abstract
This article is the result of a multiconstituency consortium's 18-month collaboration on the critical issue of quality of life for people undergoing chemotherapy for cancer and those who care for them. It is intended to supplement existing practice guidelines by establishing some easy-to-use guiding principles that can be understood by all concerned constituencies and that are practical to apply.
Source and rights
Published by The Journal of oncology management : the official journal of the American College of Oncology Administrators, 1997. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- Consortium for the Prevention and Management of the Serious Side Effects of Cancer Chemotherapy
- Published
- 1997
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- The Journal of oncology management : the official journal of the American College of Oncology Administrators
- PubMed
- 10174928
- Added to Prognia
- 24 July 2026
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
